Bank of Montreal’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,629
| Closed | -$228K | – | 3516 |
|
|
2024
Q4 | $228K | Sell |
10,629
-382,190
| -97% | -$9.3M | ﹤0.01% | 2700 |
|
|
2024
Q3 | $11.7M | Sell |
392,819
-191,770
| -33% | -$4.77M | 0.01% | 976 |
|
|
2024
Q2 | $9.08M | Buy |
584,589
+533
| +0.1% | +$6.44K | ﹤0.01% | 1045 |
|
|
2024
Q1 | $6.49M | Sell |
584,056
-1,444
| -0.2% | -$14.4K | ﹤0.01% | 1122 |
|
|
2023
Q4 | $7.54M | Buy |
585,500
+362,996
| +163% | +$2.97M | ﹤0.01% | 1122 |
|
|
2023
Q3 | $1.77M | Sell |
222,504
-64,336
| -22% | -$594K | ﹤0.01% | 1766 |
|
|
2023
Q2 | $2.51M | Buy |
286,840
+76,594
| +36% | +$639K | ﹤0.01% | 1687 |
|
|
2023
Q1 | $3.39M | Buy |
210,246
+1,695
| +0.8% | +$21.7K | ﹤0.01% | 1415 |
|
|
2022
Q4 | $2.63M | Sell |
208,551
-689
| -0.3% | -$10.2K | ﹤0.01% | 1655 |
|
|
2022
Q3 | $4.51K | Sell |
209,240
-900
| -0.4% | -$19.3K | ﹤0.01% | 1405 |
|
|
2022
Q2 | $5.42K | Buy |
210,140
+17,714
| +9% | +$491K | ﹤0.01% | 1379 |
|
|
2022
Q1 | $7.61M | Sell |
192,426
-1,337
| -0.7% | -$52.1K | ﹤0.01% | 1272 |
|
|
2021
Q4 | $8.89M | Sell |
193,763
-49,908
| -20% | -$2.61M | ﹤0.01% | 1002 |
|
|
2021
Q3 | $14.8M | Buy |
243,671
+23,801
| +11% | +$1.81M | 0.01% | 1087 |
|
|
2021
Q2 | $21.2M | Buy |
219,870
+187,644
| +582% | +$14.9M | 0.01% | 874 |
|
|
2021
Q1 | $2.35M | Sell |
32,226
-5,878
| -15% | -$456K | ﹤0.01% | 1706 |
|
|
2020
Q4 | $3.08M | Buy |
38,104
+5,449
| +17% | +$316K | ﹤0.01% | 1617 |
|
|
2020
Q3 | $1.41M | Buy |
32,655
+27,999
| +601% | +$945K | ﹤0.01% | 1814 |
|
|
2020
Q2 | $164K | Buy |
+4,656
| New | +$133K | ﹤0.01% | 2825 |
|
|
2020
Q1 | – | Sell |
-104,374
| Closed | -$2.25M | – | 4164 |
|
|
2019
Q4 | $2.25M | Buy |
104,374
+63,932
| +158% | +$1.47M | ﹤0.01% | 1816 |
|
|
2019
Q3 | $915K | Sell |
40,442
-10,469
| -21% | -$290K | ﹤0.01% | 2119 |
|
|
2019
Q2 | $1.83M | Buy |
50,911
+5,779
| +13% | +$185K | ﹤0.01% | 1742 |
|
|
2019
Q1 | $1.42M | Buy |
45,132
+44,635
| +8,981% | +$1.3M | ﹤0.01% | 1864 |
|
|
2018
Q4 | $12K | Buy |
497
+267
| +116% | +$6.86K | ﹤0.01% | 3831 |
|
|
2018
Q3 | $7K | Sell |
230
-13,522
| -98% | -$253K | ﹤0.01% | 4022 |
|
|
2018
Q2 | $169K | Sell |
13,752
-4,054
| -23% | -$46.5K | ﹤0.01% | 2848 |
|
|
2018
Q1 | $142K | Hold |
17,806
| – | – | ﹤0.01% | 2797 |
|
|
2017
Q4 | $130K | Buy |
+17,806
| New | +$111K | ﹤0.01% | 2892 |
|
Other funds holding CDNA
AIM
OAM
HRCM
FAM
GS
Bank of Montreal's CDNA Position: Q1 2025 in Review
Bank of Montreal sold out of CareDx (CDNA) in Q1 2025, closing a stake of 10,629 shares — an estimated $228K sold.
Bank of Montreal first reported a position in CDNA in Q4 2017 and held it in 28 quarters. The position peaked at $21.2M in Q2 2021. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.
- Bank of Montreal reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
- Bank of Montreal sold 10,629 CareDx shares in Q1 2025, an estimated $228K.
- Bank of Montreal first reported a position in CareDx in Q4 2017 and held it in 28 quarters.
- Bank of Montreal's CareDx position peaked at $21.2M in Q2 2021.
- 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.
Based on Bank of Montreal's 13F filing for Q1 2025, filed 13 May 2025.